The Effect of Medication Review in High-risk Emergency Department Patients

Status Completed

Clinical Trial Summary

Adverse drug events are unintended and harmful events related to medication use and a leading cause of emergency department visits, unplanned hospital admissions and deaths. In the emergency department, physicians frequently misdiagnose adverse drug events leading to treatment delays. Our objective is to evaluate the effect of pharmacist-led medication review in high-risk emergency department patients on prolonged hospital stay.

This prospective multi-centre, quasi-randomized study is nested within an existing quality improvement program. Triage nurses flag incoming emergency department patients at high-risk for adverse drug events by applying a clinical decision rule consisting of four variables (co-morbid conditions, antibiotic use within 7 days, medication changes within 28 days, and age). Consecutive eligible high-risk patients are enrolled into the medication review study, and systematically allocated to pharmacist-led medication review or usual care. In the intervention group, medication review pharmacists collect best-possible medication histories, review the patient's medications for appropriateness and adverse drug events, and communicate the results of medication review to patients, caregivers and physicians. In the usual care group, physicians refer patients to onsite pharmacists for medication management questions on an as needed basis. Health outcomes are assessed using anonymized data linkage to administrative health databases. The primary outcome is the percent of days spent in hospital during the first 30 days after the index emergency department visit

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Adverse Drug Events
Adverse Drug Reactions
Drug-Related Side Effects and Adverse Reactions
Medication-related Problems

Clinical Trial Details

NCT number	NCT02122965
Study type	Interventional
Source	University of British Columbia
Contact
Status	Completed
Phase	N/A
Start date	December 2012
Completion date	February 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02239237` - Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
Completed	`NCT01179867` - Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge	N/A
Completed	`NCT02191358` - YouScript IMPACT Registry	N/A
Completed	`NCT02059044` - Information Systems-enabled Outreach Program for Adverse Drug Events	N/A
Completed	`NCT01164137` - Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care	N/A
Completed	`NCT02482025` - The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial	N/A
Completed	`NCT04692220` - Drug-Related Problems : Focus on Age and Diabetes
Completed	`NCT02378220` - Pharmacogenetic Testing Among Home Health Patients	N/A
Completed	`NCT01337063` - Multi-Center Medication Reconciliation Quality Improvement Study	N/A
Completed	`NCT02593916` - Response to Medication Registry
Completed	`NCT00013143` - Patient Profiling and Provider Feedback to Reduce Adverse Drug Events	N/A
Withdrawn	`NCT00606606` - Reducing Adverse Drug Events in the Nursing Home	N/A
Completed	`NCT02026453` - Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy	N/A
Completed	`NCT02805270` - Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization	N/A
Completed	`NCT01764204` - Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years	N/A
Completed	`NCT01531088` - Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes	N/A
Completed	`NCT00780572` - Implementation of Real-time ADE Surveillance and Decision Support	N/A
Completed	`NCT01091038` - Improving Safety by Basic Computerizing Outpatient Prescribing	Phase 2/Phase 3
Recruiting	`NCT04479553` - Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.
Active, not recruiting	`NCT00740675` - Ambulatory Medication Reconciliation Following Hospital Discharge	N/A